文献速递呼吸危重症与机械通气

机器学习分类器模型可利用易得临床数据识别急性呼吸窘迫综合征表型

Machine Learning Classifier Models Can Identify Acute Respiratory Distress Syndrome Phenotypes Using Readily Available Clinical Data.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

本研究利用三项随机对照试验队列(n=2,022)训练梯度提升机器学习模型,用24项入组时变量对ARDS表型进行分类,并在SAILS队列(n=745)中验证。模型在验证队列中AUC达0.95(95%CI 0.94-0.96),高炎症表型的炎症生物标志物和90天死亡率显著更高,且与治疗存在显著交互作用。

要点

  • 机器学习模型仅用易得临床数据即可准确识别ARDS表型,验证队列AUC为0.95。
  • 模型分类的高炎症表型炎症生物标志物更高,90天死亡率38% vs 24%。
  • 模型分类表型在ALVEOLI和FACTT队列中与治疗存在显著交互作用。

核心结论

  • 基于易得临床数据的机器学习模型可准确识别ARDS表型,有望实现床旁快速表型识别。

研究设计与样本

  • 研究使用三个随机对照试验队列(ARMA、ALVEOLI、FACTT;n=2,022)作为训练集,SAILS队列(n=745)作为验证集。
  • 采用梯度提升机器学习算法,使用入组时24项变量(人口学、生命体征、实验室和呼吸变量)开发分类器模型。
  • 模型性能以潜类别分析衍生的表型为参照进行评估。

主要发现

  • 主要分析中,模型在验证队列准确分类表型,AUC为0.95(95%CI 0.94-0.96)。
  • 以概率 cutoff 0.5 分类时,模型分类的高炎症表型炎症生物标志物(IL-6、IL-8、sTNFR-1;P < 0.0001)和90天死亡率(38% vs 24%;P = 0.0002)显著更高。
  • 以ALVEOLI(AUC 0.94;95%CI 0.92-0.96)和FACTT(AUC 0.94;95%CI 0.92-0.95)为验证队列时模型准确度相似。
  • 在ALVEOLI(P = 0.0113)和FACTT(P = 0.0072)队列中观察到临床分类器模型分配的表型与治疗存在显著交互作用。

临床怎么用

  • 该模型仅需常规临床数据即可在床旁快速识别ARDS表型,无需血浆生物标志物检测。
  • 识别高炎症表型可能有助于筛选对特定治疗反应更佳的患者,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Two distinct phenotypes of acute respiratory distress syndrome (ARDS) with differential clinical outcomes and responses to randomly assigned treatment have consistently been identified in randomized controlled trial cohorts using latent class analysis. Plasma biomarkers, key components in phenotype identification, currently lack point-of-care assays and represent a barrier to the clinical implementation of phenotypes.Objectives: The objective of this study was to develop models to classify ARDS phenotypes using readily available clinical data only.Methods: Three randomized controlled trial cohorts served as the training data set (ARMA [High vs. Low Vt], ALVEOLI [Assessment of Low Vt and Elevated End-Expiratory Pressure to Obviate Lung Injury], and FACTT [Fluids and Catheter Treatment Trial]; n = 2,022), and a fourth served as the validation data set (SAILS [Statins for Acutely Injured Lungs from Sepsis]; n = 745). A gradient-boosted machine algorithm was used to develop classifier models using 24 variables (demographics, vital signs, laboratory, and respiratory variables) at enrollment. In two secondary analyses, the ALVEOLI and FACTT cohorts each, individually, served as the validation data set, and the remaining combined cohorts formed the training data set for each analysis. Model performance was evaluated against the latent class analysis-derived phenotype.Measurements and Main Results: For the primary analysis, the model accurately classified the phenotypes in the validation cohort (area under the receiver operating characteristic curve [AUC], 0.95; 95% confidence interval [CI], 0.94-0.96). Using a probability cutoff of 0.5 to assign class, inflammatory biomarkers (IL-6, IL-8, and sTNFR-1; P < 0.0001) and 90-day mortality (38% vs. 24%; P = 0.0002) were significantly higher in the hyperinflammatory phenotype as classified by the model. Model accuracy was similar when ALVEOLI (AUC, 0.94; 95% CI, 0.92-0.96) and FACTT (AUC, 0.94; 95% CI, 0.92-0.95) were used as the validation cohorts. Significant treatment interactions were observed with the clinical classifier model-assigned phenotypes in both ALVEOLI (P = 0.0113) and FACTT (P = 0.0072) cohorts.Conclusions: ARDS phenotypes can be accurately identified using machine learning models based on readily available clinical data and may enable rapid phenotype identification at the bedside.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Sinha P, Churpek MM, Calfee CS, et al. Machine Learning Classifier Models Can Identify Acute Respiratory Distress Syndrome Phenotypes Using Readily Available Clinical Data. Am J Respir Crit Care Med. 2020. PMID: 32551817. doi:10.1164/rccm.202002-0347OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。